论文部分内容阅读
目的:研究多索茶碱与氨茶碱治疗支气管哮喘的临床疗效。方法:择于2014年2月至2015年3月于我院就医的支气管哮喘病患78例,所有病患均通过入院前确诊,满足支气管哮喘患病标准及诊断依据,然后按照随机数表均分为两组,即研究组与对照组。各组病患为39例,其中研究组采用抗菌培养结合抗菌药物治疗,而对照组则采用一般临床抗菌治疗,同时对比各组病患的治疗效果,计算总体有效率,并且展开组间数据对比。结果:根据本次研究结果显示,在治疗效果对比方面,研究组39例病患总体有效率为92.31%;而对照组39例病患总体有效率为76.92%;以上各组总体有效率对比存在显著差异,具有统计学意义(P<0.05)。结论:相对氨茶碱治疗,以多索茶碱治疗支气管哮喘,疗效更加显著,起效更为迅速,不良反应较少,存在临床推广意义。
Objective: To study the clinical efficacy of doxofylline and aminophylline in the treatment of bronchial asthma. Methods: Totally 78 patients with bronchial asthma who were admitted to our hospital from February 2014 to March 2015 were enrolled. All patients were diagnosed before admission to meet the criteria of asthma and the basis for diagnosis. According to the random number table Divided into two groups, the study group and the control group. The patients in each group were 39 cases, in which the study group was treated with antibacterial culture combined with antibacterial drugs, while the control group was treated with general clinical antibacterial therapy, while the treatment effect of each group was compared to calculate the overall effective rate, . Results: According to the results of this study, the overall effective rate of the study group was 92.31% in the comparison of the treatment effect, while the overall effective rate of the 39 patients in the control group was 76.92%. The overall effective rate of the above groups existed Significant difference was statistically significant (P <0.05). Conclusion: Relative to aminophylline treatment, the treatment of bronchial asthma with doxofylline has more significant curative effect, more rapid onset and fewer adverse reactions, which have clinical significance.